A total of 15 recommendations were tracked for Anthem Biosciences IPO. Out of 15 , 12 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 0 for Avoid and 3 hasn't given any rating. In terms of percentage 80% institutes has rated Anthem Biosciences IPO for subscribe.
